DeepEn is at the forefront of developing innovative holographic endoscopy technology, specifically designed for minimally invasive applications in neuroscience. Their flagship product, the NeuroDeep® microendoscope, utilizes advanced holographic techniques to transform a single optical fiber into a high-resolution imaging device capable of penetrating deep tissue regions. This technology allows for real-time imaging of neuronal structures and activity with minimal tissue damage, making it a powerful tool for researchers studying brain connectivity and function. The NeuroDeep platform supports various imaging modalities, including structural imaging and functional calcium imaging, enabling scientists to observe cellular dynamics and blood flow in previously inaccessible areas of the brain.

The company’s commitment to advancing neurophotonics is underscored by its successful collaborations and funding initiatives, including a significant grant from the European Innovation Council. DeepEn's technology has been validated through rigorous research and has already shown promise in imaging applications involving neurons and cancer cells in animal models. With a focus on translating cutting-edge research into practical tools for neuroscience, DeepEn aims to empower researchers in their quest to understand and treat neurological disorders, thereby contributing to the future of medical diagnostics and therapeutic strategies.

Germany

DeepEn offers hair-thin endomicroscopy solutions capable of subcellular resolution and high-speed observations within hard-to-access body regions. Our minimally invasive devices are used in research and diagnostics, helping to advance our understanding of diseases and microscopic processes deep inside sensitive tissues in real time.

DeepEn was founded in 2024 as a spinoff from the Department for Holographic Endoscopy, led by Prof Dr Tomas Cizmar at Leibniz Institute of Photonic Technology in Jena, Germany. Our Managing Director is Dr Sergey Turtaev.

DeepEn

Company Details